Intense Competition in Proteomics Market: The company faces significant competition from established players and new entrants in the rapidly evolving proteomics and life science tools industries, which could limit market share and pricing power.

Limited Product Portfolio and Market Adoption: Seer's revenue is primarily derived from its Proteograph platform; slow or limited market adoption of this core technology, or failure to successfully develop and commercialize new products, could significantly impact financial performance.

Intellectual Property Protection Challenges: The ability to protect its proprietary technology through patents, trade secrets, and other means is crucial for Seer's success, and any failure to do so, or challenges to its existing IP, could negatively affect its competitive position.